BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1463444)

  • 1. A competitive inhibitor of phospholipase A2 decreases surfactant phosphatidylcholine degradation by the rat lung.
    Fisher AB; Dodia C; Chander A; Jain M
    Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):407-11. PubMed ID: 1463444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of acidic Ca2+-independent phospholipase A2 in synthesis of lung dipalmitoyl phosphatidylcholine.
    Fisher AB; Dodia C
    Am J Physiol; 1997 Feb; 272(2 Pt 1):L238-43. PubMed ID: 9124374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lung calcium-independent phospholipase A2 by surfactant protein A.
    Fisher AB; Dodia C; Chander A
    Am J Physiol; 1994 Sep; 267(3 Pt 1):L335-41. PubMed ID: 7943260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phospholipase A2 inhibitor decreases generation of thiobarbituric acid reactive substance during lung ischemia-reperfusion.
    al-Mehdi AB; Dodia C; Jain MK; Fisher AB
    Biochim Biophys Acta; 1993 Mar; 1167(1):56-62. PubMed ID: 8461333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a calcium-independent acidic phospholipase A2 from rat lung.
    Wang R; Dodia CR; Jain MK; Fisher AB
    Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):131-7. PubMed ID: 7998924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation and reutilization of alveolar phosphatidylcholine by rat lungs.
    Fisher AB; Dodia C; Chander A
    J Appl Physiol (1985); 1987 Jun; 62(6):2295-9. PubMed ID: 3038828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal-type PLA2 and turnover of alveolar DPPC.
    Fisher AB; Dodia C
    Am J Physiol Lung Cell Mol Physiol; 2001 Apr; 280(4):L748-54. PubMed ID: 11238016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2.
    Fisher AB; Dodia C; Feinstein SI; Ho YS
    J Lipid Res; 2005 Jun; 46(6):1248-56. PubMed ID: 15772425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel nontoxic inhibitor of the activation of NADPH oxidase reduces reactive oxygen species production in mouse lung.
    Lee I; Dodia C; Chatterjee S; Zagorski J; Mesaros C; Blair IA; Feinstein SI; Jain M; Fisher AB
    J Pharmacol Exp Ther; 2013 May; 345(2):284-96. PubMed ID: 23475902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of smoke inhalation on surfactant phospholipids and phospholipase A2 activity in the mouse lung.
    Oulton M; Moores HK; Scott JE; Janigan DT; Hajela R
    Am J Pathol; 1991 Jan; 138(1):195-202. PubMed ID: 1987765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of acidic Ca(2+)-independent phospholipase A2 of bovine lung.
    Akiba S; Dodia C; Chen X; Fisher AB
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Jun; 120(2):393-404. PubMed ID: 9787801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung phospholipid metabolism in transgenic mice overexpressing peroxiredoxin 6.
    Fisher AB; Dodia C; Yu K; Manevich Y; Feinstein SI
    Biochim Biophys Acta; 2006 Jul; 1761(7):785-92. PubMed ID: 16815092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of lung surfactant secretion by phospholipase A2.
    Liu L
    J Cell Biochem; 1999 Jan; 72(1):103-10. PubMed ID: 10025671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes.
    Fisher AB; Dodia C
    J Lipid Res; 1996 May; 37(5):1057-64. PubMed ID: 8725157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylcholine metabolism of rat trachea in relation to lung parenchyma and surfactant.
    Rau GA; Dombrowsky H; Gebert A; Thole HH; von der Hardt H; Freihorst J; Bernhard W
    J Appl Physiol (1985); 2003 Sep; 95(3):1145-52. PubMed ID: 12909600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar uptake of lipid and protein components of surfactant.
    Fisher AB; Dodia C; Chander A
    Am J Physiol; 1991 Oct; 261(4 Pt 1):L334-40. PubMed ID: 1928369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the complex of bovine pancreatic phospholipase A2 with the inhibitor 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol,
    Sekar K; Eswaramoorthy S; Jain MK; Sundaralingam M
    Biochemistry; 1997 Nov; 36(46):14186-91. PubMed ID: 9369492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental regulation of re-uptake of phosphatidylcholine by type II alveolar epithelium.
    Kresch MJ; Cipriani LA; Lu H; Christian C
    Biochim Biophys Acta; 1994 Jan; 1210(2):167-73. PubMed ID: 8280766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic mediators increase pulmonary retention of instilled phospholipids.
    Fisher AB; Dodia C; Chander A
    J Appl Physiol (1985); 1985 Sep; 59(3):743-8. PubMed ID: 2997104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
    Arbibe L; Koumanov K; Vial D; Rougeot C; Faure G; Havet N; Longacre S; Vargaftig BB; Béréziat G; Voelker DR; Wolf C; Touqui L
    J Clin Invest; 1998 Sep; 102(6):1152-60. PubMed ID: 9739049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.